Fennec Pharmaceuticals (FENC) Operating Income (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Operating Income came in at -$2.6 million in Q4 2025, down 173.45% YoY from $3.5 million in Q4 2024, and down 1251.32% on a QoQ basis from -$189000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Operating Income (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Operating Income data on file, last reported at -$2.6 million in Q4 2025.
- Quarterly Operating Income fell 173.45% year-over-year to -$2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.3 million (down 344.67% YoY) and the FY2025 annual result came in at -$6.3 million, down 344.63% from the prior year.
- Operating Income fell to -$2.6 million in Q4 2025, from -$189000.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $13.7 million in Q1 2024 to a low of -$7.9 million in Q3 2022.
- A 5-year average of -$2.8 million and a median of -$4.0 million in 2021 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 360.78% in 2024, down 411.5% in 2024.
- Tracing FENC's Operating Income over 5 years: stood at -$4.2 million in 2021, then sank by 45.83% to -$6.1 million in 2022, then surged by 70.37% to -$1.8 million in 2023, then soared by 48.62% to -$934000.0 in 2024, then plunged by 173.45% to -$2.6 million in 2025.
- The last three Operating Income figures came in at -$2.6 million (Q4 2025), -$189000.0 (Q3 2025), and -$2.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Mn |
| Dec 31, 2025 | -2.55 Mn |
| Sep 30, 2025 | -189,000.00 |
| Jun 30, 2025 | -2.73 Mn |
| Mar 31, 2025 | -808,000.00 |
| Dec 31, 2024 | -934,000.00 |
| Sep 30, 2024 | -5.20 Mn |
| Jun 30, 2024 | -5.04 Mn |
| Mar 31, 2024 | 13.74 Mn |
| Dec 31, 2023 | -1.82 Mn |
| Sep 30, 2023 | -1.02 Mn |
| Jun 30, 2023 | -4.67 Mn |
| Mar 31, 2023 | -5.27 Mn |
| Dec 31, 2022 | -6.14 Mn |
| Sep 30, 2022 | -7.90 Mn |
| Jun 30, 2022 | -5.01 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | -4.21 Mn |
| Sep 30, 2021 | -4.17 Mn |
| Jun 30, 2021 | -3.92 Mn |